X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (458) 458
Book Review (182) 182
Publication (57) 57
Book / eBook (4) 4
Book Chapter (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (418) 418
humans (344) 344
animals (185) 185
male (183) 183
female (141) 141
ticlopidine - analogs & derivatives (123) 123
clopidogrel (120) 120
middle aged (104) 104
platelet aggregation inhibitors - therapeutic use (102) 102
pharmacology & pharmacy (88) 88
platelet aggregation - drug effects (81) 81
aged (79) 79
ticlopidine - therapeutic use (76) 76
treatment outcome (76) 76
blood platelets - drug effects (75) 75
platelet aggregation inhibitors - pharmacology (70) 70
percutaneous coronary intervention (69) 69
purinergic p2 receptor antagonists (68) 68
hematology (66) 66
purinergic p2y receptor antagonists - therapeutic use (66) 66
adenosine (65) 65
aspirin (65) 65
acute coronary syndromes (64) 64
atp (61) 61
adenosine - analogs & derivatives (58) 58
cardiac & cardiovascular systems (57) 57
peripheral vascular disease (57) 57
prasugrel (57) 57
purinergic p2y receptor antagonists - pharmacology (57) 57
blood platelets - metabolism (56) 56
platelet aggregation inhibitors - adverse effects (54) 54
neurosciences (51) 51
blood platelets (48) 48
platelets (48) 48
rats (48) 48
adult (47) 47
mice (47) 47
p2y (47) 47
ticagrelor (47) 47
antiplatelet therapy (44) 44
platelet function tests (44) 44
risk factors (44) 44
abridged index medicus (43) 43
aggregation (43) 43
medicine & public health (42) 42
prospective studies (42) 42
inflammation (41) 41
inhibition (41) 41
platelet aggregation inhibitors - administration & dosage (41) 41
cardiology (40) 40
cardiovascular (40) 40
receptors, purinergic p2y12 - metabolism (40) 40
ticlopidine - pharmacology (40) 40
activation (39) 39
aspirin - therapeutic use (39) 39
dose-response relationship, drug (39) 39
receptors, purinergic p2y12 (39) 39
prasugrel hydrochloride (38) 38
receptors, purinergic p2 - metabolism (38) 38
acute coronary syndrome - drug therapy (37) 37
analysis (37) 37
drug therapy (37) 37
platelet activation - drug effects (37) 37
purinergic p2y receptor antagonists - administration & dosage (37) 37
cell biology (36) 36
p2y receptor (36) 36
purinergic p2y receptor antagonists - adverse effects (36) 36
thrombosis (36) 36
coronary heart disease (35) 35
myocardial-infarction (35) 35
drug therapy, combination (34) 34
physiological aspects (34) 34
receptors, purinergic p2y12 - drug effects (34) 34
extracellular atp (33) 33
purinergic receptors (32) 32
signal transduction (32) 32
ticlopidine - administration & dosage (32) 32
acute coronary syndrome (31) 31
cardiac patients (31) 31
disease models, animal (31) 31
drug resistance (31) 31
receptors (30) 30
research (30) 30
time factors (30) 30
acute myocardial-infarction (29) 29
article (29) 29
health aspects (29) 29
adenosine monophosphate - analogs & derivatives (28) 28
adenosine - therapeutic use (27) 27
adenosine triphosphate - metabolism (27) 27
artery-disease (27) 27
cardiovascular disease (27) 27
care and treatment (27) 27
ticlopidine - adverse effects (27) 27
platelet aggregation (26) 26
rodents (26) 26
stents (26) 26
adenosine - pharmacology (25) 25
hemorrhage - chemically induced (25) 25
receptors, purinergic p2y12 - blood (25) 25
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 07/2015, Volume 99, Issue 7, pp. 903 - 908
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2016, Volume 163, pp. 122 - 131.e2
Purpose To compare the efficacies and safety profiles of 3% diquafosol and 0.1% sodium hyaluronate in patients with dry eye after cataract surgery. Design... 
Ophthalmology | OCULAR SURFACE | CORNEAL | WORKSHOP | POPULATION | HIGHER-ORDER ABERRATIONS | DISEASE | INS365 | OPHTHALMOLOGY | MODEL | SECRETION | HYALURONIC-ACID | Staining and Labeling - methods | Polyphosphates - adverse effects | Prospective Studies | Phacoemulsification - adverse effects | Humans | Middle Aged | Purinergic P2Y Receptor Agonists - adverse effects | Viscosupplements - adverse effects | Male | Polyphosphates - administration & dosage | Dry Eye Syndromes - diagnosis | Uracil Nucleotides - adverse effects | Viscosupplements - administration & dosage | Ophthalmic Solutions | Female | Surveys and Questionnaires | Uracil Nucleotides - administration & dosage | Fluorescent Dyes - administration & dosage | Hyaluronic Acid - adverse effects | Hyaluronic Acid - administration & dosage | Purinergic P2Y Receptor Agonists - administration & dosage | Dry Eye Syndromes - drug therapy | Tears - chemistry | Lissamine Green Dyes - administration & dosage | Visual Acuity | Fluorescein - administration & dosage | Aged | Tears - physiology | Lens Implantation, Intraocular | Administration, Topical | Dry Eye Syndromes - etiology | Eye | Medical colleges | Cataract | Care and treatment | Surgery | Ophthalmic drugs | Hyaluronic acid | Fluorescein | Cataracts | Sodium | Clinical trials | Eye diseases | Inflammation | FDA approval | Patient satisfaction | Eye surgery | Eye care products | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Advances in Therapy, ISSN 0741-238X, 11/2014, Volume 31, Issue 11, pp. 1169 - 1181
Journal Article
NATURE, ISSN 0028-0836, 04/2015, Volume 520, Issue 7547, pp. 317 - 317
In response to adenosine 59-diphosphate, the P2Y(1) receptor (P2Y(1)R) facilitates platelet aggregation, and thus serves as an important antithrombotic drug... 
COMPLEX | NUCLEOTIDE RECEPTORS | RECOGNITION | SMALL-MOLECULE | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | PROTEIN-COUPLED RECEPTORS | PURINERGIC RECEPTORS | ANTAGONISTS | DISCOVERY | AGONIST
Journal Article
Journal Article
Medical Science Monitor, ISSN 1234-1010, 04/2015, Volume 21, pp. 1131 - 1137
Journal Article
Cornea, ISSN 0277-3740, 11/2004, Volume 23, Issue 8, pp. 784 - 792
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 08/2015, Volume 13, Issue 8, pp. 1494 - 1502
Based on animal and human data, phosphoinositide 3-kinase (PI3K)β is a promising antithrombotic target. However, the relation between efficacy and bleeding... 
12 | antiplatelet agents | bleeding | receptor antagonists | P2Y | PI 3‐kinase | acetylsalicylic acid | PI 3-kinase | Acetylsalicylic acid | Antiplatelet agents | Bleeding | Purinergic P2Y Receptor Antagonists - administration & dosage | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | ortho-Aminobenzoates - adverse effects | Receptors, Purinergic P2Y12 - drug effects | Male | Blood Platelets - enzymology | Protein Kinase Inhibitors - adverse effects | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Purinergic P2Y Receptor Antagonists - adverse effects | Sweden | ortho-Aminobenzoates - pharmacokinetics | Receptors, Purinergic P2Y12 - blood | Aspirin - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Adult | Models, Animal | Phosphatidylinositol 3-Kinase - blood | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Drug Therapy, Combination | Cyclooxygenase 1 - blood | Platelet Aggregation Inhibitors - adverse effects | Protein Kinase Inhibitors - pharmacokinetics | ortho-Aminobenzoates - administration & dosage | Pyrimidinones - adverse effects | Cyclooxygenase Inhibitors - administration & dosage | Adenosine - administration & dosage | Cross-Over Studies | Protein Kinase Inhibitors - administration & dosage | Animals | Pyrimidinones - pharmacokinetics | Adenosine - analogs & derivatives | Dogs | Pyrimidinones - administration & dosage | Hemorrhage - chemically induced | Cyclooxygenase Inhibitors - adverse effects | Index Medicus
Journal Article
Journal Article